Iprivask
NDC Package 83055-111-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Iprivask is a . Marketed by Canyon Pharmaceuticals, Inc., this product is identified by NDC 83055-111 and is authorized under FDA application NDA021271.

Identification & Billing

NDC Package Code
83055-111-12
Package Description
10 TRAY in 1 BOX / 1 VIAL in 1 TRAY / 15.75 mg in 1 VIAL
Product Code
83055-111
11-Digit Billing Format
83055011112

Clinical Specifications

Proprietary Name
Iprivask
Dosage Form
-

Regulatory & Marketing

Labeler Name
Canyon Pharmaceuticals, Inc.
FDA Application #
NDA021271
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-10-2010
End Marketing Date
11-01-2010
Listing Expiration
11-01-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83055-111-12 identifies a specific commercial package of 10 tray in 1 box / 1 vial in 1 tray / 15.75 mg in 1 vial of Iprivask, labeled by Canyon Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Canyon Pharmaceuticals, Inc. on June 10, 2010. The current certification is valid through November 01, 2010.

How is this Canyon Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83055011112. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83055-111-12
11-Digit CMS (5-4-2)
83055-0111-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.